Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Thyroid Neoplasms × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Pain 3 Pain, Postoperative 2 Agnosia 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Postoperative Complications 1 Ovarian Cysts 1 Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Intraoperative Complications 1 Goiter 1 Colorectal Neoplasms 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Advanced Ovarian Cancer 1 Abdominal Neoplasms 1

Interventions

Iodine-131 3 Thyrotropin Alfa 2 vandetanib 1 lenvatinib 1 fosbretabulin 1 combretastatin 1 cabozantinib 1 Thyroidectomy 1 Sorafenib 1 Ropivacaine 1 Radiotherapy 1 Paclitaxel 1 Neck Dissection 1 Metformin 1 Epinephrine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02112370 2017-08-04

REBT

Seoul National University Hospital

Phase 3 Completed

148 enrolled 17 charts

Goiter, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡